dactinomycin has been researched along with Sarcoma, Kaposi in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (80.00) | 18.7374 |
| 1990's | 4 (13.33) | 18.2507 |
| 2000's | 1 (3.33) | 29.6817 |
| 2010's | 1 (3.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuchimoto, Y; Hirobe, S; Kamagata, S; Kumagai, M; Kuroda, T; Matsuoka, K; Morikawa, N; Morikawa, Y | 1 |
| ROCHLIN, DB | 1 |
| Büsing, CM; Kempmann, G; Kösters, W; Rethel, R | 1 |
| Olweny, CL | 1 |
| Durosinmi-Etti, FA; Ketiku, KK | 1 |
| Vogel, CL | 1 |
| Bayley, AC | 2 |
| Bezwoda, WR; Lachter, J; Spencer, D; Stein, ME | 1 |
| Bonavida, B; Mori, S; Murakami-Mori, K; Nakamura, S | 2 |
| Ashkenazi, A; Bonavida, B; Mori, S; Murakami-Mori, K; Nakamura, S | 1 |
| Campos, LT; Lanzotti, VJ; Samuels, ML; Sinkovics, JG | 1 |
| Hartmann, D; Obrecht, JP; Obrist, R | 1 |
| Burns, JC; Goplerud, DR; Hall, DJ | 1 |
| Baker, LH; Benjamin, RS; Gottlieb, JA; Moon, TE; O'Bryan, RM | 1 |
| Atine, I; Kaddumukasa, A; Magrath, I; Olweny, CL; Owor, R; Ziegler, JL | 1 |
| Bergmann, L; Helm, EB; Runne, U; Saller, R; Schöfer, H | 1 |
| Fauci, AS; Gelmann, EP; Jacob, J; Lane, HC; Longo, D; Masur, H; Preble, OT; Steis, R; Wesley, M | 1 |
| Coates, R; Evans, WK; Fanning, MM; Garvey, B; Klein, M; Read, SE; Shepherd, FA | 1 |
| Egorov, LV; Perevodchikova, NI; Terent'eva, TG | 1 |
| Falkson, G | 1 |
| Bank, S; King, H; Novis, BH | 1 |
| Bhana, D; Kyalwazi, SK; Master, SP | 1 |
| Halama, J | 1 |
| Lwanga, SK; Mbidde, EK; Olweny, CL; Toya, T | 1 |
| Kyalwazi, SK; Owor, R; Primack, A; Vogel, CL | 1 |
| Briers, P; Dhru, D; Kyalwazi, SK; Owor, R; Primack, A; Vogel, CL | 1 |
| Kyalwazi, SK; Taylor, JF; Templeton, AC; Templeton, CJ; Vogel, CL | 1 |
| Stehlin, JS | 1 |
3 review(s) available for dactinomycin and Sarcoma, Kaposi
| Article | Year |
|---|---|
Management of Kaposi's sarcoma. Chemotherapy I.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Carmustine; Dactinomycin; Humans; Immunosuppressive Agents; Prednisone; Razoxane; Sarcoma, Kaposi; Vinca Alkaloids | 1981 |
[Importance of dactinomycin in the current therapy of tumors].
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Clinical Trials as Topic; Dactinomycin; Dogs; Drug Resistance; Dysgerminoma; Female; Humans; Kidney Neoplasms; Male; Melanoma; Neoplasms; Pregnancy; Sarcoma; Sarcoma, Kaposi; Soft Tissue Neoplasms; Testicular Neoplasms; Trophoblastic Neoplasms; Uterine Neoplasms; Wilms Tumor | 1985 |
[Kaposi's sarcoma in children].
Topics: Age Factors; Biopsy; Burkitt Lymphoma; Child; Cyclophosphamide; Dactinomycin; Diagnosis, Differential; Humans; Methotrexate; Sarcoma, Kaposi; Sex Factors; Triethylenemelamine | 1972 |
8 trial(s) available for dactinomycin and Sarcoma, Kaposi
| Article | Year |
|---|---|
Management of Kaposi's sarcoma. Chemotherapy II.
Topics: Bleomycin; Carmustine; Clinical Trials as Topic; Dacarbazine; Dactinomycin; Drug Therapy, Combination; Humans; Razoxane; Sarcoma, Kaposi; Uganda; Vincristine | 1981 |
Occurrence, clinical behaviour and management of Kaposi's sarcoma in Zambia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Delivery of Health Care; Drug Evaluation; Epirubicin; Female; Humans; Incidence; Male; Neoplasm Staging; Prognosis; Quality of Health Care; Sarcoma, Kaposi; Skin Neoplasms; Vincristine; Zambia | 1991 |
Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Dactinomycin; Doxorubicin; Humans; Interferon Type I; Palliative Care; Random Allocation; Recombinant Proteins; Sarcoma, Kaposi; Time Factors; Vinblastine; Vincristine | 1987 |
Combination chemotherapy and alpha-interferon in the treatment of Kaposi's sarcoma associated with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dactinomycin; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Humans; Interferon Type I; Male; Middle Aged; Prognosis; Prospective Studies; Sarcoma, Kaposi; Skin Neoplasms; Vinblastine | 1988 |
[Importance of dactinomycin in the current therapy of tumors].
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Clinical Trials as Topic; Dactinomycin; Dogs; Drug Resistance; Dysgerminoma; Female; Humans; Kidney Neoplasms; Male; Melanoma; Neoplasms; Pregnancy; Sarcoma; Sarcoma, Kaposi; Soft Tissue Neoplasms; Testicular Neoplasms; Trophoblastic Neoplasms; Uterine Neoplasms; Wilms Tumor | 1985 |
Treatment of Kaposi's sarcoma by combination of actinomycin-D, vincristine and imidazole carboxamide (nsc-45388): results of a randomized clinical trial.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Dacarbazine; Dactinomycin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Prognosis; Sarcoma, Kaposi; Triazenes; Uganda; Vincristine | 1974 |
Treatment of Kaposi's sarcoma with a combination of actinomycin D and vincristine. Results of a randomized clinical trial.
Topics: Adult; Aged; Dactinomycin; Female; Humans; Leukopenia; Male; Middle Aged; Remission, Spontaneous; Sarcoma, Kaposi; Thrombocytopenia; Vincristine | 1973 |
Treatment of Kaposi's sarcoma with actinomycin-D and cyclophosphamide: results of a randomized clinical trial.
Topics: Adult; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Sarcoma, Kaposi; Skin Neoplasms | 1971 |
20 other study(ies) available for dactinomycin and Sarcoma, Kaposi
| Article | Year |
|---|---|
Vincristine, actinomycin D, cyclophosphamide chemotherapy resolves Kasabach-Merritt syndrome resistant to conventional therapies.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Hemangioendothelioma; Humans; Infant, Newborn; Kasabach-Merritt Syndrome; Male; Platelet Count; Sarcoma, Kaposi; Treatment Failure; Vincristine | 2012 |
THE THERAPY OF SARCOMAS BY ISOLATION PERFUSION.
Topics: Aorta; Aorta, Abdominal; Bone Neoplasms; Carotid Arteries; Chemotherapy, Cancer, Regional Perfusion; Chondrosarcoma; Dactinomycin; Dogs; Fibrosarcoma; Iliac Artery; Iliac Vein; Leiomyosarcoma; Liposarcoma; Lymphoma, Non-Hodgkin; Melphalan; Mesothelioma; Neoplasms; Neuroblastoma; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Kaposi; Subclavian Artery; Vena Cava, Inferior | 1964 |
[A rare form of Kaposi's sarcoma with intestinal symptoms (author's transl)].
Topics: Adult; Colon; Colonic Neoplasms; Cyclophosphamide; Dactinomycin; Humans; Intestinal Neoplasms; Intestine, Small; Male; Sarcoma, Kaposi; Vincristine | 1980 |
The treatment of Kaposi's sarcoma by combination chemotherapy in Nigeria.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Female; Humans; Male; Middle Aged; Sarcoma, Kaposi; Vincristine | 1984 |
Role of surgery in the management of Kaposi's sarcoma in Lusaka Zambia.
Topics: Adolescent; Adult; Aged; Amputation, Surgical; Arm; Arthrodesis; Dactinomycin; Electrocoagulation; Humans; Leg; Male; Middle Aged; Razoxane; Sarcoma, Kaposi; Vincristine; Zambia | 1981 |
Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dactinomycin; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Remission Induction; Retrospective Studies; Sarcoma, Kaposi; Skin Neoplasms; South Africa; Survival Rate; Treatment Failure; Treatment Outcome; Vinblastine; Vincristine | 1995 |
Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in K
Topics: Acquired Immunodeficiency Syndrome; Antibodies, Monoclonal; Antigens, CD; Calcium-Calmodulin-Dependent Protein Kinases; Carrier Proteins; Cell Division; Dactinomycin; Death Domain Receptor Signaling Adaptor Proteins; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Growth Inhibitors; Growth Substances; Guanine Nucleotide Exchange Factors; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Sarcoma, Kaposi; Threonine; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tyrosine | 1999 |
Sensitization of AIDS-Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D.
Topics: Acquired Immunodeficiency Syndrome; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Caspases; Cell Death; Dactinomycin; Drug Resistance, Neoplasm; Drug Synergism; fas Receptor; Fibroblasts; Humans; Leukocytes, Mononuclear; Ligands; Membrane Glycoproteins; Recombinant Proteins; Sarcoma, Kaposi; Solubility; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1999 |
Actinomycin D-mediated sensitization of AIDS-Kaposi's sarcoma cells to Fas-mediated apoptosis: involvement of the mitochondrion-dependent pathway.
Topics: Acquired Immunodeficiency Syndrome; Adaptor Proteins, Signal Transducing; Apoptosis; Blotting, Western; Carrier Proteins; Caspase 8; Caspase 9; Caspases; Cell Survival; Cytochrome c Group; Dactinomycin; Enzyme Activation; Enzyme Inhibitors; fas Receptor; Fas-Associated Death Domain Protein; Humans; Mitochondria; Sarcoma, Kaposi; Signal Transduction; Tumor Cells, Cultured | 2002 |
Chemotherapy for advanced Kaposi sarcoma.
Topics: Aged; Bleomycin; Dacarbazine; Dactinomycin; Doxorubicin; Humans; Male; Mechlorethamine; Middle Aged; Procarbazine; Sarcoma, Kaposi; Skin Neoplasms; Vinblastine; Vincristine | 1975 |
[Kaposi sarcoma. A short review on a rare disease].
Topics: Adolescent; Africa; Antibodies, Viral; Cytomegalovirus; Dactinomycin; Environmental Exposure; Humans; Imidazoles; Lymphadenitis; Male; Middle Aged; Sarcoma, Kaposi; Switzerland; Vincristine | 1978 |
Kaposi's sarcoma of the vulva: a case report and brief review.
Topics: Antineoplastic Agents; Dacarbazine; Dactinomycin; Drug Therapy, Combination; Female; Humans; Middle Aged; Sarcoma, Kaposi; Vincristine; Vulvar Neoplasms | 1979 |
Advances in the chemotherapy of soft tissue sarcomas.
Topics: Adult; Antineoplastic Agents; Child; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Leiomyosarcoma; Neoplasm Metastasis; Remission, Spontaneous; Rhabdomyosarcoma; Sarcoma; Sarcoma, Kaposi; Soft Tissue Neoplasms; Time Factors; Vincristine | 1977 |
Childhood Kaposi's sarcoma: clinical features and therapy.
Topics: Adolescent; Child; Child, Preschool; Dacarbazine; Dactinomycin; Female; Humans; Infant; Lymphadenitis; Male; Remission, Spontaneous; Sarcoma, Kaposi; Sex Factors; Vincristine | 1976 |
[Acute exanthematous eruption of multiple Kaposi sarcomas of the AIDS type in a female drug-addict. Successful chemotherapy with vincristine, bleomycin and dactinomycin].
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dactinomycin; Deltaretrovirus; Female; Heroin Dependence; Humans; Neoplasms, Multiple Primary; Retroviridae Infections; Sarcoma, Kaposi; Sex Work; Skin; Skin Neoplasms; Vincristine | 1986 |
Some aspects of the use of cytostatic drugs in dermatology.
Topics: Colchicine; Dactinomycin; Fluorouracil; Humans; Melanoma; Methotrexate; Mycosis Fungoides; Nitrogen Mustard Compounds; Psoriasis; Sarcoma, Kaposi; Skin Neoplasms; Vinblastine | 1966 |
Kaposi's sarcoma presenting with diarrhea and protein-losing enteropathy.
Topics: Adolescent; Albumins; Chromium Radioisotopes; Cyclophosphamide; Dactinomycin; Diarrhea; Edema; Humans; Intestinal Neoplasms; Male; Penicillin V; Protein-Losing Enteropathies; Radiography; Sarcoma, Kaposi; Stomach Neoplasms; Ulcer; Vincristine | 1974 |
Actinomycin D in malignant Kaposi's sarcoma.
Topics: Adult; Aged; Bone Neoplasms; Dactinomycin; Drug Eruptions; Female; Foot Diseases; Hand; Humans; Lymph Nodes; Male; Middle Aged; Nausea; Sarcoma, Kaposi; Skin Neoplasms; Stomatitis; Thigh; Triaziquone; Vomiting | 1971 |
Effective treatment of Kaposi's sarcoma with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
Topics: Adult; Amides; Antineoplastic Agents; Blood Cell Count; Dactinomycin; Drug Resistance; Humans; Imidazoles; Male; Middle Aged; Remission, Spontaneous; Sarcoma, Kaposi; Skin Neoplasms; Triazenes | 1973 |
Hyperthermic perfusion with chemotherapy for cancers of the extremities.
Topics: Arm; Burns; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Edema; Femoral Neoplasms; Foot Diseases; Hemangiosarcoma; Hemoglobinuria; Hemolysis; Hot Temperature; Humans; Leg; Melanoma; Melphalan; Neoplasm Metastasis; Sarcoma; Sarcoma, Ewing; Sarcoma, Kaposi; Time Factors | 1969 |